Founded
Address
Sanderling Ventures
400 South El Camino Real
Suite 1200
San Mateo, CA 94402
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30602
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 57| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Pulsar Vascular | Medical device company specialized in the design and developed of innovative medical devices for the endovascular treatment of neurovascular disorders | N/A | |||
|
|
Regen Biologics Inc | N/A | ||||
|
|
Regeneron Pharmaceuticals Inc | Neurotrophic factors company for nerve repair and regeneration. | N/A | |||
|
|
SkyePharma Inc | Drug delivery company developied oral and inhalation products. | N/A | |||
|
|
Sotera Wireless Inc | An early stage medical device manufacturer | N/A | |||
|
|
Stentor Inc | Enterprise-wide imaging and information solution company for the healthcare industry. | N/A | |||
|
|
Stereotaxis Inc | Medical device company engaged in the field of image guided interventional surgery | N/A | |||
|
|
Taligen Therapeutics Inc | Series A | ||||
|
|
TheraVida Inc | Pharmaceutical company focused on the treatment of urological disorders. | N/A | |||
|
|
Theregen Inc | Regenerative medicine company developing Anginera, an epicardial patch, for the treatment of heart disease. | N/A | |||
|
|
Tomophase Corp | N/A | ||||
|
|
Torax Medical Inc | Series D | ||||
|
|
Torax Medical Inc | Series B | ||||
|
|
UltraBridge Inc | Developer of a technology solutions specifically designed to help senior care companies. | N/A | |||
|
|
Ventritex Inc | Supplied a line of products for high risk cardiac patients | N/A | |||
|
|
ViaCyte Inc | N/A | ||||
|
|
Vical Inc | N/A | ||||
|
|
Xoma Corp | N/A | ||||
|
|
Actimis Pharmaceuticals Inc | Biopharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders. | N/A | |||
|
Aderis Pharmaceuticals Inc | Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. | Series D Initial investment | |||
|
|
Aderis Pharmaceuticals Inc | Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. | N/A Initial investment | |||
|
|
Advanced Cardiovascular Systems | N/A Initial investment | ||||
|
|
Altor Bioscience Corp | Biopharmaceutical company developing a new class of therapeutic products for the treatment of cancer, viral infections and autoimmune diseases. | N/A | |||
|
|
Artielle ImmunoTherapeutics Inc | Developer of compound for the treatment of multiple sclerosis. | N/A | |||
|
|
AtheroGenics Inc | N/A Initial investment |